Cipla Ltd.
| BSE: 500087 | Sector: Health care |
| NSE: CIPLA | ISIN Code: INE059A01026 |
| BSE 00:00 | 18 Jun | 960.25 |
9.35 (0.98%) |
OPEN
950.30 |
HIGH
967.45 |
LOW
945.55 |
| NSE 00:00 | 18 Jun | 960.90 |
9.95 (1.05%) |
OPEN
950.95 |
HIGH
967.65 |
LOW
945.35 |
| OPEN | 950.30 |
| PREVIOUS CLOSE | 950.90 |
| VOLUME | 144164 |
| 52-Week high | 982.05 |
| 52-Week low | 618.85 |
| P/E | 31.37 |
| Mkt Cap.(Rs cr) | 77,444 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Cipla Ltd. (CIPLA) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 952.30 | -10.60 | -1.10 | 13266.48 |
| Cipla | 960.25 | 9.35 | 0.98 | 12659.15 |
| Sun Pharma.Inds. | 668.40 | 3.70 | 0.56 | 12531.93 |
| Dr Reddy's Labs | 5284.60 | -3.70 | -0.07 | 11850.40 |
| Lupin | 1157.15 | -5.50 | -0.47 | 11025.66 |
| Apollo Hospitals | 3221.90 | -18.45 | -0.57 | 9794.50 |
| Glenmark Pharma. | 640.75 | 1.50 | 0.23 | 6712.63 |
| Alkem Lab | 3137.20 | -30.10 | -0.95 | 6677.08 |
| Cadila Health. | 620.20 | -0.05 | -0.01 | 6347.40 |
| Torrent Pharma. | 2898.35 | -54.95 | -1.86 | 6168.44 |
| Divi's Lab. | 4192.80 | -108.30 | -2.52 | 5310.57 |
| Alembic Pharma | 975.50 | -15.25 | -1.54 | 5051.44 |
| Ipca Labs. | 1990.85 | -37.70 | -1.86 | 4337.82 |
| Piramal Enterp. | 2233.90 | 70.85 | 3.28 | 4219.19 |
| Abbott India | 16507.55 | -21.40 | -0.13 | 4093.14 |
| Glaxosmi. Pharma | 1515.55 | -27.70 | -1.79 | 3224.68 |
| Jubilant Pharmo | 734.60 | -23.35 | -3.08 | 3139.90 |
| Sanofi India | 7628.65 | -122.80 | -1.58 | 2901.90 |
| Laurus Labs | 593.15 | -17.90 | -2.93 | 2797.34 |
| Ajanta Pharma | 1949.50 | -20.25 | -1.03 | 2718.59 |
Quick Links for Cipla:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
